Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Size enhanced fibrinolytic enzymes: limitations of plasma inactivation

Size enhanced fibrinolytic enzymes: limitations of plasma inactivation

US Patent 6214594 · Granted Apr 10, 2001

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Biocompatible implants and methods of making and attaching the same2014
Method of expressing proteins with disulfide bridges with enhanced yields and ac2014
Method of expressing proteins with disulfide bridges with enhanced yields and ac2014
Method of expressing proteins with disulfide bridges2014
Inhibiting integrin receptor binding with non-native monomeric disintegrin or mo2012
Methods of expressing proteins with disulfide bridges2012
Combination therapy for treatment of cancer2011
Chimeric disintegrin domain2010
Contortrostatin (CN) and methods for its use in preventing metastasis and other 2010
Contortrostatin CN and methods for its use in preventing metastasis and other co2007
Contortrostain (CN) and methods for its use in preventing metastasis and other c2004
Thrombolytic agents with antithrombotic activity1999